![PDF) Tailoring an activatable peptide-metal prodrug to successfully fight breast cancer Oncol Res Treat 39(suppl1) VII-191 (2016) ISSN 2296-5270 e-ISBN 978-3-318-05831-4 ID 0180 ISSN PDF) Tailoring an activatable peptide-metal prodrug to successfully fight breast cancer Oncol Res Treat 39(suppl1) VII-191 (2016) ISSN 2296-5270 e-ISBN 978-3-318-05831-4 ID 0180 ISSN](https://i1.rgstatic.net/publication/305210107_Tailoring_an_activatable_peptide-metal_prodrug_to_successfully_fight_breast_cancer_Oncol_Res_Treat_39suppl1_VII-191_2016_ISSN_2296-5270_e-ISBN_978-3-318-05831-4_ID_0180_ISSN/links/5784e36308ae3f355b4bd178/largepreview.png)
PDF) Tailoring an activatable peptide-metal prodrug to successfully fight breast cancer Oncol Res Treat 39(suppl1) VII-191 (2016) ISSN 2296-5270 e-ISBN 978-3-318-05831-4 ID 0180 ISSN
![PDF) Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients PDF) Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients](https://i1.rgstatic.net/publication/301536445_Polymorphisms_in_androgen_metabolism_genes_AR_CYP1B1_CYP19_and_SRD5A2and_prostate_cancer_risk_and_aggressiveness_in_Bulgarian_patients/links/578771de08ae95560407a47b/largepreview.png)
PDF) Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients
![nextcloud/passman - #adessonews adessonews #retefin retefin Finanziamenti Agevolazioni Norme e Tributi nextcloud/passman - #adessonews adessonews #retefin retefin Finanziamenti Agevolazioni Norme e Tributi](https://i0.wp.com/www.sassarinews.eu/wp-content/uploads/2021/06/nextcloud-passman.png?fit=400%2C199&ssl=1)